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Abstract
Evidence for the effectiveness of population health screenings to reduce the burden of
non-communicable diseases in low income countries remains very limited. We inves-
tigate the sustained effects of a health screening in Malawi where individuals received
a referral letter if they had elevated blood pressure. Using a regression discontinuity
design and a matching estimator, we find that receiving a referral letter reduced blood
pressure and the probability of being hypertensive by about 22 percentage points four
years later. These lasting effects are explained by a 20 percentage points increase in the
probability of being diagnosed with hypertension. There is also evidence of an increase
in the uptake of medication, while we do not identify improvements in hypertension-
related knowledge or risk behaviors. The health screening had some positive effects
on mental health. Overall, this study suggests that population-based hypertension
screening interventions are an effective tool to improve health in low-income contexts.
Keywords: Health Screening, Hypertension, Non-communicable Diseases, Regression
Discontinuity Design, Matching Estimator, Low Income Countries, Malawi
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1 Introduction
Individuals often have very imperfect knowledge about their own health (Foot et al. 2014).
This lack of knowledge can inhibit critical health decision making and result in preventable
elevated mortality and morbidity (Kenkel 1991; Ruhm 2016). Limited knowledge about
own health is of particular concern when severe medium/long-term health risks do not
manifest itself in instantaneous disease symptoms. Examples include: HIV infection, with
infected individuals facing significantly elevated morbidity and mortality as the disease
progresses, while experiencing virtually no specific indications of being HIV+ for a pro-
longed period of time (Tomar 1994); diseases with well-defined genetic risk factors but
delayed manifestation of symptoms, including breast cancer or some inherited disorders
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such as Huntington’s disease (Müller et al. 2018; Oster et al. 2013); or conditions such as in-
sulin resistance where early detection and intervention can reduce cumulative organ dam-
age and delay disease progression to adult-onset diabetes (American Diabetes Association
2002). In this category of illnesses is also cardiovascular disease (CVD), an eminent emerg-
ing disease burden in low- and middle-income countries (LMICs) where individuals with
high blood pressure generally experience few noticeable indications of hypertension, while
at the same time, face heightened morbidity and mortality risks through stroke, heart at-
tacks, metabolic syndrome, memory loss or dementia (Geldsetzer et al. 2019; Lackland and
Weber 2015; Wang et al. 2006).
Improving individuals’ knowledge about their own health has the potential to reduce
morbidity and mortality in the above cases, as informed individuals can respond to latent
health risks through appropriate prevention and/or risk-reduction strategies. For exam-
ple, HIV testing is a pathway to access antiretroviral treatment (ART), a diagnosis of hy-
pertension can be followed up by behavioral changes or biomedical treatment to reduce
CVD risks, women may opt to undergo mastectomy if they are identified as carriers of
BRCA1 or BRCA2 genes, etc. Because of the basic insight that knowledge is key to pre-
vention and treatment, health screenings have been promoted and implemented in many
contexts as a tool to improve population health and enhance individuals’ ability to effec-
tively invest in heath across the life course. In high-income countries, health screenings
are routinely conducted as part of regular health care visits (Swenson and Ebell 2016). In
countries affected by the HIV epidemic, HIV testing has become an essential component
of pre-natal care, and door-to-door HIV testing, widespread screening as part of National
HIV Testing Days, and HIV self-testing have all been promoted as effective health policy
(CDC 2020; Ganguli et al. 2009; WHO 2016). Demand for such testing services is often high
(Thornton 2008). In contrast to these well established screening programs, currently very
limited NCD screening is conducted in LMICs, which is in striking contrast to the rapidly
rising NCD disease burden (GBD Collaborators 2018; NCD-RisC Collaboration 2017). As
a result, poor and rural populations are likely to have a high prevalence of undiagnosed
risk factors (Geldsetzer et al. 2019; Islam et al. 2014).
Population-based health screenings have been promoted in LMICs to address this ris-
ing NCD-related morbidity and mortality (Benziger et al. 2016; Greenberg et al. 2011).
Screening for hypertension is particularly relevant as the prevalence of hypertension in
LMICs ranges between 20% and 40% (Ibrahim and Damasceno 2012). Yet, important con-
cerns remain as to whether NCDs-screening in LICs is effective for improving population
health for several reasons. First, individuals need to have basic NCDs-related health liter-
acy in order to be able to act based on obtaining knowledge about hypertension or similar
NCDs-risk factors. Even if the health screening is accompanied by the respective health
information about the determinants, behavioral and biomedical risk reduction strategies,
because of limited health literacy and knowledge individuals may not be able to respond to
the provided health information in ways that results in longer-term morbidity and mortal-
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ity benefits. Second, prevention and treatment guidelines for NCDs and CVDs specifically
in LICs are often based on established guidelines for higher-income contexts. However,
individuals’ ability to effectively respond to NCDs-related information revealed during
heath screenings is made more complex in LICs by the fact that CVD and certain other
NCDs are partially driven by a different set of risk factors than in higher-income contexts
(WHO 2013a). Third, health systems in LICs are often inadequately prepared and equipped
in terms of staffing, equipment, guidelines and medications to diagnose, manage and/or
treat NCDs (Cappuccio and Miller 2016; Nulu et al. 2016). Individuals who present them-
selves to the health system based on NCD-related health screenings, therefore, often may
not be able to receive treatment or guidance that allows them to reduce their underlying
health risks.
The existing evidence about the effectiveness of NCDs-related health screenings is
mixed, including the one generated in high-income countries with sophisticated health
systems and relatively good NCDs-related health literacy (Krogsbøll et al. 2012). While
there is some evidence about the effectiveness of NCDs-related health screenings in high
and middle-income populations (Chen et al. 2019; Rodriguez-Lesmes et al. 2017), to date,
no population-based evidence exists about its effectiveness in rural LICs contexts. More-
over, the effectiveness of NCDs-related health screenings in poor and/or rural LMICs pop-
ulations cannot be inferred by relying on research evidence generated in higher-income
countries, given the distinctly different health systems, distinct risk factors for common
NCDs, and low NCDs-related health literacy in the population. The experience in LICs
with HIV testing however provides useful guidance on how the benefits of population-
based screening multiply once access to the respective health care is made available. Prior
to the widespread availability of antiretroviral treatment (ART), the benefits of widespread
population-based HIV testing were controversial (Denison et al. 2008). Once access to ART
became widely available, HIV testing outside of clinical settings has became the gateway
to accessing ART and the benefits of testing are widely accepted (CDC 2020).
This paper fills an important gap in the research on the effectiveness of population-
based screening for NCDs in LICs by evaluating the long-term effects of a simple and in-
expensive population-based health screening for hypertension in Malawi. Specifically, we
investigate if screening for high blood pressure among mature adults with high prevalence
of hypertension can lead to significant long-term gains in hypertension-related health out-
comes such as reductions in blood pressure levels, or uptake in diagnosis and medica-
tion. The causal identification of these effects exploits a study design feature that pro-
vided “at-risk” study participants with a referral letter for further assessment by a health
care provider if they were measured with blood pressure above a specific threshold (160
mmHg systolic or 110 mmHg diastolic blood pressure). We pursue two empirical strate-
gies to evaluate the effects of the referral letter. Using a sharp regression discontinuity
design (RDD), we compare the outcomes for individuals who are right above the cutoff
for receiving the referral letter (treatment group) to the outcomes for those who are right
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below the cutoff (control group). The second strategy, a nearest-neighbor matching esti-
mator, exploits the availability of multiple blood pressure measurements to estimate the
causal effects of getting a referral letter on hypertension-related health outcomes away
from the cutoff of 160 mmHg systolic blood pressure. This second strategy matches in-
dividuals based on their mean blood pressure measurements while the RDD strategy is
implicitly matching individuals on their maximum blood pressure measurements. The
two methods complement each other: the discontinuity design controls best for selection,
while matching allows to explore the results away from the critical cutoff and provides
estimates with higher external validity. The results yield very similar estimates across the
two different methods, although they vary in some cases in their statistical power.
Overall, our study finds that hypertension health screening was effective, and that pro-
viding referral letters to at-risk respondents resulted in a long-term reduction of blood
pressure. More specifically, the regression discontinuity local average treatment effect on
the change in systolic blood pressure between 2013 and 2017 is around -14.3 units of mil-
limeters of mercury (mmHg), which corresponds to about half a standard deviation in sys-
tolic blood pressure. The average treatment effect on the treated measured by the matching
estimator is very similar at about -12.6 mmHg. We also find a negative treatment effect of
about half a standard deviation for diastolic blood pressure (-6 mmHg) using both meth-
ods. As a consequence of this drop in blood pressure levels, individuals in the treatment
group ended up being 22% less likely to be hypertensive in 2017. Such sustained long-
term effects have not previously been documented for NCD-related health screening in
rural LIC populations with low levels of health literacy, high NCD prevalence and limited
access to NCDs care through the health system.
The observed drop in blood pressure among at-risk respondents subsequent to the
MLSFH-MAC health screening was most likely the consequence of a sharp increase in the
rate of diagnosis for hypertension. Individuals who received the referral letter have a 20
percentage points higher chance to have been diagnosed as hypertensive by a medical
provider within two years before the follow-up assessment in 2017. The increase in diag-
nosis rate that resulted from the referral letter also seemed to have lead to a higher share of
individuals who were treated for hypertension by taking medication, although the effects
are less precisely estimated and are statistically significant only in the matching estimates.
The effect on the probability of currently taking medication is 13 percentage points in the
matching specification which is rather large considering that the share of people taking
medication is very low (9.4%).
Efforts to reduce blood pressure through medication could be reinforced or hampered
by other hypertension-related risk behaviors such as unhealthy diet and lack of physical
exercise. We fail to find any positive effects of the referral letter on these risk behaviors. If
anything, we find some negative effects, according to Western recommendations, such as
an increase in sugar intake and a decrease in physical exercise in the matching estimates
only. These counter-intuitive behavioral responses are possibly related to the fact that
Penn Population Center Working Paper 2020-41
https://repository.upenn.edu/psc_publications/41
4
Health Screening for Emerging Disease Burdens
some risk factors for CVDs in LICs are different from those established in higher-income
contexts (our study population, for example, is physically very active, has almost no obe-
sity or consumption of western diets, and nevertheless, is characterized by widespread
hypertension Kohler et al. 2018b). It is therefore not clear that standard recommendations
about how to reduce high blood pressure, which are generally derived based on evidence
from Western high-income populations, are pertinent to LIC populations. Individuals in
our study population might also aware that their options for changing dietary behaviors
or physical activity levels are very limited, and that any such changes might overall have
no (or even negative) effects on their health and well-being. We also do not find any effect
on improved hypertension knowledge such as knowing the symptoms of hypertension
and its treatment options. Finally, we do not find that the referral had negative effects on
subjective physical and mental health. If anything, we find some evidence of a positive
effect on subjective mental health in the RDD specification.
In summary, our analyses contribute to the literature on health care demand for newly
emerging disease burdens in LICs, and more broadly, to the literature on how individu-
als respond to new information about their own health in terms of life-course decision-
making (Dupas and Miguel 2017). Our results are consistent with findings from high- and
middle-income countries that evaluated the effects of population-based health screening
for hypertension using similar identification strategies (Chen et al. 2019; Rodriguez-Lesmes
et al. 2017), although very few other study—and none in LMICs—have examined sustained
population-based effects of health screening during a 4-year period. Our study expands
this research by documenting the effects of NCD-related health screening in a very poor
LIC context, and by investigating the pathways through which screening resulted in re-
duced blood pressure and improved hypertension management by affecting knowledge,
diagnosis and medical treatment. Our study is also the first to exploit a dual methodolog-
ical approach for establishing the causal effects of health screening. While the RDD strat-
egy provides valid causal inference at the cutoff and has high internal validity, the matching
strategy we employ allows to increase the external validity of our findings by estimating the
effects of the referral for hypertension on different sets of individuals, therefore providing
important insights for policies aiming at changing the different cutoffs for screening high
blood pressure.
2 Non-communicable diseases (NCDs) and Health Screening in LICs
The prevalence of hypertension in African countries is high (Figure 1). While there have
been important steps to improve treatment coverage for communicable diseases such as
HIV and malaria (Lozano et al. 2012; Murray et al. 2012), the health care systems in these
countries are ill-prepared to face the emergency of the rapidly increasing burden of hyper-
tension and other NCDs (Beaglehole et al. 2008; Kämpfen et al. 2018). Moreover, despite the
shifting burden of disease in SSA LICs, individuals’ knowledge about NCD risk factors,
Penn Population Center Working Paper 2020-41
https://repository.upenn.edu/psc_publications/41
5
Health Screening for Emerging Disease Burdens
Figure 1: Prevalence of high blood pressure (systolic), by sex, 2015 (%, age-standardized)
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the symptoms and the importance of preventive health care to reduce NCD risk factors are
generally very limited (Boateng et al. 2017; Das et al. 2017; Sjørensen et al. 2012; WHO 2015).
NCD-related healthcare and knowledge is hampered by the fact that adequate information
and resources are not provided to sub-populations at greatest risk and/or most affected by
chronic conditions. Importantly this includes older populations above age 45, the majority
of whom continues to live in rural areas, has very low levels of formal education and has
very limited access to adequate NCD-related healthcare (Boateng et al. 2017; Kohler et al.
2018a; Malawi MOH and WHO 2010).
Policy options for addressing issues related to hypertension and the shifting burden of
disease in LICs face formidable implementation challenges due to strained health systems
that are coping with a dual burden of infectious and non-communicable diseases, have
restricted resources for NCD-related health promotion and prevention, and serve popula-
tions with low NCD-related health literacy. Among the various measures that can poten-
tially be put in place to contain the rising epidemic of hypertension and NCDs more gen-
erally, access to preventive care, screening interventions and early detection of health con-
ditions are perhaps the ones that are the more efficient and recommended (WHO 2013b).
Screening and early detection of health conditions, especially of high-blood pressure, have
important benefits (American Heart Association 2019; Siu 2015). Indeed, high-blood pres-
sure screening has no harms and facilitates the detection of associated CVDs diseases at an
early stage and thus prevent individuals from going through unaffordable health care and
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more rigorous treatments that complications would require (Dehmer et al. 2017; Howard
et al. 2010; Sheridan et al. 2003; Siu 2015; Wald et al. 1999). Given the limited health systems
in SSA LICs, understanding the health behaviors and responses of individuals in the face
of NCD awareness and screening is therefore crucial to contain the increasing burden of
hypertension and NCDs more generally (Dupas 2011).
To date, however, very little evidence exists on the effectiveness of population-based
health screening efforts focused on NCDs in LICs countries, in contrast to the extensive
literature on screening (testing) for HIV and some other communicable diseases in LICs
(e.g., Cohen et al. 2015; Delavande and Kohler 2012; Gong 2014; Thornton 2008).1 A general
finding is that households in low-income countries spend a significant portion of their
resources on remedial health care but very little in preventive health care (Dupas 2011). A
growing research evidence supports interventions to increase investments in preventive
health care (Dupas and Miguel 2017), among which health screening is perhaps the most
efficient, particularly for newly proliferating NCDs (Strong et al. 2005; WHO 2014).
3 Context and Data
3.1 Context
Our study is set in the context of Malawi, a SSA country with one of the lowest income
per capita in the world, equal to about 2% of the global average, and a Human Develop-
ment Index that is ranked 172 out of 189 countries (HDI2018 = .485). In rural areas, where
our study is based and most Malawians (85%) live, the majority of individuals engage in
home production of crops, complemented by some market activities. About 60% of the
rural population is considered poor in 2016/17, thus having a total consumption that does
not provide 2,400 calories per day per person plus some basic nonfood items, and 24%
is considered ultra-poor (Malawi NSO 2018). The HIV epidemic reached its peak in the
2000s when the availability of antiretroviral treatment (ART) started to reduce the number
of HIV-related deaths and initiated rebound of life expectancy (GBD Collaborators 2018;
Jahn et al. 2008). NCDs have since become the major cause of death, as is also the case in
other LMICs. Underlying this shifting disease burden is a high and increasing prevalence
of NCD-risk factors such as hypertension (Figure 1). Our study population is no excep-
1Specifically, among the studies that have analyzed screening interventions for communicable diseases in
Africa, Thornton (2008) finds that a financial incentive substantially increases the likelihood that an individual
travels to learn the result of an HIV test in Malawi. Delavande and Kohler (2012) use the same intervention to
look at beliefs over transmission risk and risky sexual behavior, and find that receiving an HIV-negative test
result implies higher subjective expectations about being HIV-positive after two years, and individuals tend
to have larger prediction errors about their HIV status after learning their HIV status. Gong (2014) looks at a
randomized HIV testing campaign in Kenya and Tanzania and find that being tested reduce the likelihood of
getting an STI, and document behavioral responses to HIV tests when tests provide unexpected information.
Cohen et al. (2015) randomize access to rapid malaria diagnostic tests in Kenya where overtreatment of malaria
is very common, and find that those who learn their status are less likely to buy the antimalarial drug but
around half of individuals testing negative still purchase the drug.
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tion: more than than 60% of the mature adults in 2013 were at least pre-hypertensive, and
42.30% had Stage 1 or Stage 2 hypertension, exposing more than two-fifth of respondents
to substantially elevated CVD risks (Kohler et al. 2018b).2 In Malawi and other LICs, how-
ever, the increasing importance of NCDs is not matched with a significant increase in finan-
cial and human resources dedicated to NCDs-related health care (Beaglehole et al. 2008).
Hospitals in Malawi are understaffed and the medical staff is poorly trained to treat NCDs
(Malawi Ministry of Health and ICF International 2014). In our study areas, about 85 per-
cent of health facilities do not have staff recently trained to provide services for diabetes or
for cardiovascular diseases. As a consequence of limited NCD-related heath care services,
people are not routinely screened for NCDs, a situation that is especially pronounced in
rural areas. As a result, very few people get tested for hypertension either because they are
not aware of the risks associated with high blood pressure or because routine high blood
pressure testing is not done as part of health examinations (Msyamboza et al. 2012).3
3.2 The Mature Adults Cohort of the Malawi Longitudinal Study of Families and
Health (MLSFH-MAC)
Our analyses use data from the Mature Adults Cohort of the Malawi Longitudinal Study of
Families and Health (MLSFH-MAC), a longitudinal cohort study of individuals (mostly)
aged 45 years and older in rural areas in three districts in Malawi (Mchinji, Rumphi and
Balaka).4 The cohort was established in 2012, with follow-up waves in 2013, 2017 and
2018 collecting extensive information on physical, mental and cognitive health, NCDs-
related health knowledge and NCDs-related health care utilization, socioeconomic well-
being, household production and consumption, household structure and family change.
The study population is broadly representative of the 45+ years old rural population in
Malawi. The MLSFH and MLSFH-MAC Cohort Profiles provides detailed information on
sampling procedures, study design and study instruments (Kohler et al. 2015, 2020).
2Interestingly, individuals in Malawi and more generally in SSA LICs lack the presence of conventional risk
factors such as obesity or lack of physical activity that are associated with hypertension. In the MLSFH-MAC
study population, only 15% of study participants are overweight (BMI between 25 to 30) and less than 5% are
obese (BMI ≥ 30).
3For example, the WHO STEPS Survey conducted in 2009 in Malawi found that 75% of the participants
never had their blood pressure measured before and 94.9% of the individuals who were tested with high
blood pressure were unaware of their hypertensive conditions (Msyamboza et al. 2012).
4There are no birth certificates and/or other reliable records of when individuals are born in Malawi.
MLSFH-MAC makes several attempts to verify age of the study participants. Eligibility for enrollment in
MLSFH-MAC was determined by ages reported in 2010 and earlier. A small number of individuals reported
ages below 45 at enrollment in 2012. These individuals were nevertheless enrolled in the study and this
resulted in small number of respondents below age 45. In our MLSFH-MAC sample used in this analysis
includes 12 respondents who are between ages 40 and 45.
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3.3 Screening for high blood pressure in the MLSFH-MAC
The MLSFH-MAC screened all respondents for high blood pressure in 2013 and 2017 fol-
lowing the protocol established by the U.S. Health and Retirement Study (HRS) and using
a Omron HEM-780 Blood Pressure Monitor (or comparable device). Three measurements
were taken on the respondent’s left arm, about 45 seconds apart, towards the end of the
interview. Data recorded for each measurement included systolic and diastolic blood pres-
sure, pulse, and the time of day the reading was taken.
Respondents who recorded at least one systolic blood pressure measurement above 160
mmHg, or at least one diastolic blood pressure measurement above 110 mmHg, were given
referral letters for further assessment by a health care provider. The referral letter simply
stated that the person was measured with high blood pressure surpassing 160 mmHg sys-
tolic and/or 110 mmHg diastolic and is referred to further assessment.5 The referral letter
did not provide any additional information, including where and with whom the respon-
dent should go for further assessment. Interviewers were also instructed to inform the
respondent only about their blood pressure measurements, and not to provide additional
information on blood pressure or hypertension, or indicate a diagnosis that a respondent
might be hypertensive. The referral letter is included in the Appendix.
In addition, MLSFH-MAC asked the study participants if they have been diagnosed
with hypertension by a medical provider (doctor or nurse) in the last 2 years prior to the
survey and if they were taking medication for the treatment of hypertension at the time
of the interviews in 2013 and 2017. MLSFH-MAC collected also detailed information on
respondents’ knowledge about risk factors, symptoms and treatment of hypertension.
Table 1 shows the characteristics of our baseline sample in 2013, when blood pressure
was measured for the first time in MLSFH-MAC. Specifically, the study sample is restricted
to MLSFH-MAC respondents for whom we have three non-missing systolic and diastolic
blood pressure measurements both in 2013 and 2017 (N=1,075).6 The average age of the
sample used in this analysis is about 62 years, and women represent 59% of the study
population. Respondents are almost equally distributed across the three study areas.
The mean systolic blood pressure of individuals in our sample (based on three mea-
surements) is equal to 134 mmHg in 2013 and 135 mmHg in 2017, and the corresponding
mean values for diastolic blood pressure are 86 mmHg and 84 mmHg respectively. The
average blood pressure of mature adults is thus close to the thresholds used to classify an
individual as hypertensive (i.e., currently these thresholds are 140 mmHg for systolic and
90 mmHg for diastolic blood pressure; Geldsetzer et al. 2019). In fact, according to these
5Note that the referral letter and the questionnaire mention that respondents were being referred if their
systolic or diastolic blood pressure “surpassed” 160 and 110mm/Hg, respectively. In practice, referral letters
were given if one of the systolic or diastolic blood pressure measurements was greater or equal to 160 and 110,
respectively. As robustness checks, we check that our results hold when dropping individuals who are exactly
at the 160 cutoff. Results are available upon request.
6The 2013 MLSFH-MAC survey consists of 1,257 completed interviews, among which 1,244 interviews
contained three non-missing systolic and diastolic blood pressure measurements.
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Table 1: Descriptive statistics of the MLSFH-MAC sample, 2013–2017
Mean Std. dev. 10th 90th
(1) (2) (3) (4)
Blood pressure, referral letters, health behaviors and literacy
Mean systolic BP (2017) 135.1 25.21 108 170.7
Mean systolic BP (2013) 134.26 25.31 106.3 170
Mean diastolic BP (2017) 83.67 12.69 69 100
Mean diastolic BP (2013) 85.94 12.49 71.3 102
Hypertensive 2017a .41 .49 0 1
Hypertensive in 2013a .41 .49 0 1
Received a referral letter in 2013 .19 .4 0 1
Being diagnosed in 2017 .16 .37 0 1
Taking medication in 2017 .09 .29 0 0
Know what high BP is (2017) .82 .39 0 1
Know symptoms of high BP (2017) .63 .48 0 1
Know will have to take treatment forever (2017) .78 .41 0 1
Add extra salt to plate (2017) .54 .5 0 1
Consume at least 1 sweet drink per day (2017) .24 .43 0 1
Total number of teaspoons of sugar 2.71 1.91 0 5
used in tea/coffee per day (2017)
Change in standardized SF12 physical score 0 1.05 -1.4 1.3
Change in standardized SF12 mental score 0 1.24 -1.7 1.6
Control variables
Female .59 .49 0 1
Age 62.38 10.69 50 78
Central region .31 .46 0 1
South region .34 .47 0 1
North region .35 .48 0 1
Nb of observations in benchmark sample 1075
Note: The sample is derived from the MLSFH-MAC 2013 and 2017 waves. Our analysis is based on
a sample of 1075 individuals for which we have non-missing systolic and diastolic blood pressure
measurements in 2013 and who were interviewed in 2017. The descriptive statistics of some of the
variable in Table 1 are derived from a smaller sample because of missing values. Note also that we
restricted our analysis to individuals who were 40 years or older in 2017. a: We define someone as
hypertensive if the mean systolic or diastolic blood pressure measurements was greater or equal to 140
and 90, respectively. 10th and 90th represent the 10th and 90th percentiles of the distributions, respectively.
official guidelines, the prevalence of hypertension in our sample was 41% in both years.
About 19% of the individuals in our sample received a referral letter in 2013 because
one of their systolic or diastolic blood pressure measurements was above 160 or 110, re-
spectively. The rate of individuals being diagnosed with hypertension by a medical pro-
fessional in the two years prior to the 2017 interview is almost as high, 16%, while only a
subset of them, 9%, were taking medication for hypertension at the time of the survey.
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In 2017, the vast majority of respondents know what hypertension is (82%) and 63%
of them know the characteristics of the symptoms of hypertension.7,8 Moreover, the ma-
jority of the respondents is aware that, once diagnosed as hypertensive, they will have to
take treatment forever (78%). About 24% of the study participants consume at least one
sweet drink per day and on average they add daily about 2.71 teaspoons of sugar to their
tea/coffee consumption. More than half of the respondents adds extra salt to their plate
(54%).
Figure 2 shows the distribution of mean values of systolic and diastolic blood pressure
measurements in our sample. The vertical line along the x-axis represents the threshold
that determines whether a respondent receives a referral letter because of a systolic mea-
sure above 160 and the horizontal line along the y-axis because of diastolic blood pressure
at 110. All study participants who received a referral letter, did so because they had at least
one measurement exceeding the threshold of 160 mmHg. Only 2 individuals received the
letter because of their diastolic blood pressure exceeding the threshold of 90 mmHg, as
represented by the two red x in the plot. In the empirical analysis, we exclude these 2 ob-
servations to include only respondents who received a referral letter because of their high
level of systolic blood pressure.
4 Methodology
The procedures implemented for providing a referral letter to study participants whose
blood pressure measured above a specific threshold suggests the use of a sharp regression
discontinuity design (RDD) as an appropriate application to evaluate the effects of the
referral letter on hypertension-related outcomes. The method compares individuals whose
maximum measurement of blood pressure is right below the cutoff (i.e., 160 mmHg systolic
blood pressure) with those whose maximum measurement is right above it, assuming that
individuals around the cutoff share similar observable and unobservable characteristics
with the exception of having received a referral letter.
The RDD specification benefits from strong internal validity whereas it potentially
lacks external validity as it does not reveal much about what is happening away from
the cutoff (Wing and Bello-Gomez 2018). The availability of multiple blood pressure mea-
surements for each individual allows however to estimate the causal effects of receiving a
referral letter on hypertension-related outcomes away from the critical cutoff. Indeed, one
can use a nearest-neighbor matching estimator and match individuals based on similar
blood pressure levels but where some had a maximum blood pressure above the criti-
7Health knowledge and behaviors were measured differently in 2013. Therefore, we focus on the 2017
measures only.
8Hypertension is usually asymptomatic but can result in various symptoms such as shortness of breath
and headache in some cases. In our analysis, we consider that an individual knows about the characteristics
of the symptoms of hypertension if she either says that hypertension is asymptomatic or can identify at least
one of its symptoms.
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Figure 2: Blood pressure of respondents of the 2013 MLSFH survey.
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Notes: The graphs shows average of the three measures of systolic and diastolic blood pressure
for respondents of the 2013 MLSFH-MAC survey. Dots represents mean values of systolic
(x-axis) and diastolic (y-axis) blood pressure. Small triangles represent individuals whose
maximum systolic blood pressure is at least 160 but their mean systolic blood pressure is
below 160. Small red x represent the individuals who were given a referral letter because
their diastolic blood pressure is at least 110.
cal threshold and hence received a referral letter and some other who did not fulfill the
condition to receive such a referral letter. In particular, the proposed estimator matches in-
dividuals on the mean of the three systolic blood pressure measurements, with the average
across measurements providing an estimator for the (unobserved) “true” blood pressure
of individuals at the time of screening.
Estimating corresponding effects away from the cutoff allows to determine whether
our RDD results hold for a different subset of the population (Angrist and Rokkanen 2015;
Lee and Lemieux 2010; Mealli and Rampichini 2012), hence increasing the external validity
of the findings. This could be particularly relevant and informative to policy makers in the
case they would consider lowering the threshold of the cutoff in a screening intervention
for instance. Analyzing the effects of getting a referral letter away from the cutoff can also
helps in identifying possible heterogeneous effects in the population along the distribution
of blood pressure.
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4.1 Sharp Regression Discontinuity Design (RDD)
We exploit the discontinuity in the probability of receiving a referral letter—the treat-
ment D—that is assigned based on the maximum systolic blood pressure (= the score
Xi). More formally, we observe n individuals, indexed by i = 1, 2, . . . , N whose systolic
blood pressure was measured thrice (s1i, s2i, s3i). Each respondent received a referral letter
if max(s1i, s2i, s3i) = Xi > 160, with 160 being the cutoff determining treatment D. Because
the assignment rule is Zi = 1(Xi > 160) = Di in our setting, each unit complies per-
fectly with its assignment and thus treatment corresponds to a deterministic function of the
score. Because of this deterministic decision rule at a precise cutoff, a sharp RDD design can
be used to estimate the causal effects of receiving a referral letter on hypertension-related
health outcomes.
The fundamental problem with causal inference in social sciences is that we only ob-
serve realized outcomes Yi and rarely potential outcomes (Holland 1986). In other words,
we observe the health outcomes of those who received a referral letter and those who did
not but never their counterfactual outcomes. That is, we observe:
Yi = Yi(1) · Di +Yi(0) · (1− Di) =
Yi(0) if xi < 160 = cYi(1) if xi > 160 = c (1)
with Yi(0) the outcomes of those who did not get a referral letter –our control group– and
Yi(1) the outcomes of those who got a referral letter –our treatment group–. However,
as discussed in the RDD literature (Calonico et al. 2014b, 2019; Hahn et al. 2001), one can
obtain average treatment effects at the cutoff, by comparing individuals just below and just
above it and calculating the vertical distance between E[Yi(1)|Xi] and E[Yi(0)|Xi]. Hahn
et al. (2001) showed that if the conditional expectation functions of Yi are continuous in x
at x = c, then one can derive the average treatment effect at the cutoff τrd(c) as:
τrd(c) = limx↓160E[Yi(1)|Xi]− limx↑160E[Yi(0)|Xi] = E[Yi(1)−Yi(0)|Xi = 160] (2)
Because the true functional form ofE[Yi(1)|Xi] andE[Yi(0)|Xi] is not known, we follow
the recommendations of Skovron and Titiunik (2015) and nonparametrically approximate
these regression functions with local polynomials of order 1.9 Furthermore, in our bench-
mark analysis, we use triangular weights determined by kernel functions and centered at
the cutoff c to put more weights on observations closer to c,10 and restrict our analysis to
observations that are between 160− h− and 160 + h+ with h− and h+ representing band-
widths on each side of the cutoff.11 We allow these optimal bandwidths to be different on
9We will show however as robustness checks that our results are consistent when using quadratic polyno-
mials, that is polynomials of order 2.
10Note that our results are robust to to using rectangular kernel function and hence giving equal weight to
all observations within the range [160− h−; 160+ h+].
11These bandwidths are chosen optimally following data-driven techniques developed by Calonico et al.
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both sides of the cutoff c and present results in the Appendix where we restrict our analysis
to use the same optimal bandwidths on both sides of the cutoff.12
Although not necessary for identification, we also estimate all our models with a set
of exogenous/predetermined control variables to assess the robustness of our findings to
the inclusion of covariates and potentially increase the precision of our estimates. The set
of control variables consists of sex, age and region dummy variables to control for any
systematic differences in the three regions where the MLSFH-MAC data are collected.
4.2 Matching strategy
We exploit the fact that treatment was determined based on the maximum of the three
systolic blood pressure measurements, and not on the "true" systolic blood pressure, to
estimate the causal effect of getting a referral letter away from the 160 cutoff. We do not
observe the “true" blood pressure at the time of the interview but we proxy it with the
average of the three measures Ri = mean(s1, s2, s3). Indeed, there are respondents in our
sample who were treated and therefore received a letter because max(s1, s2, s3) = Xi > 160,
but for whom their “true" blood pressure was lower than the cutoff. These respondents are
represented by small triangles in Figure 2. This setup therefore allows us to implement a
nearest-neighbor matching estimator (Abadie and Imbens 2002, 2006; Abadie et al. 2004)
to estimate the causal effect of getting a referral letter on Yi away from the cutoff, by com-
paring outcomes of interests of those who were given a referral letter with those who were
not, matching respondents with similar values of “true" blood pressure.
More formally, for this specific set of respondents, conditioning on the “true" blood
pressure Ri, Di is random because Di is based on the maximum of the three measurements
and is thus purely error-driven and independent to individual characteristics except Ri. By
assuming that Ri, can be measured by the mean of the three systolic measurements, that
is Ri = mean(s1, s2, s3), one obtains {Yi(0), Yi(1)}  Di | Ri, which implies that that con-
ditioning on Ri, treatment Di is given at random and is therefore independent to potential
outcomes.
It follows that one can estimate the potential counterfactual outcomes of each individ-
ual using information from the nearest neighbor in the opposite treatment group. That
is, for each i, Yˆi(D) = Yi if Di = D, and
∑j=Ωi Yj
|Ωi | otherwise, for D ∈ {0, 1}. In this re-
lation, Ωi represents the set of individuals j in the neighborhood of i (as defined below)
with Dj = 1− Di and |.| the cardinality function. The average treatment effect on treated
(2014a,b, 2015) using Mean Square Error (MSE) optimal bandwidth selector. In addition, the estimates of the
standard errors are computed using heteroskedasticity-robust plug-in residuals variance estimator (Calonico
et al. 2017). Note that the estimates of the variance covariance matrix are very similar when including weights
for finite sample adjustments or when using nearest neighbor variance estimator.
12For ease of comparisons across the different outcome variables we consider, we will also show results
where we impose the bandwidths on both sides of the cutoff to be identical across all the dependent variables
we consider in our analysis. Again, our results are very robust to these restrictions as well.
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(ATET)13 can then be expressed as:
τATETm =
n
∑
i=1
Di(Yˆi(1)− Yˆi(0)), (3)
where we define, for our our benchmark analysis, Ωi for each i as Ωi = {j1, ..., jK|Djk =
1− Di, ‖Ri − Rjk‖e 6 10, K > 4}, where ‖.‖e represents the euclidean distance on R which
has to be less than 10 mmHg for individual j to be in the neighborhood of individual i and
K is the number of matches. 14
To assess the quality of our matching, we report the average distance between our
treated and untreated observations. We estimate our matching model in which individuals
are matched based on a vector of characteristics x where x includes 1) only R, 2) R, sex,
region dummy variables and age, which is the same set of control variables we use in our
RDD specification.15
It is possible that people might be different not only in terms on mean blood pressure
but also in terms of variance. We may therefore be matching individuals with identical
means but with very different variance. Because the mean itself is explained by the maxi-
mum value, which may or may not be systematically different across different individual
characteristics, the mean systolic blood pressure measurements may not reflect the “true"
underlying blood pressure of the individuals, such that the treatment, conditioning on the
mean blood pressure, is not random as assumed. We therefore augment the specification
in which we include our basic set of control variables by including the standard deviation
of the three systolic blood pressure in our matching function. By doing so, we match in-
dividuals not only on their mean but also on the variance of their systolic blood pressure,
therefore increasing the chance that individuals who are matched with one another are
similar in terms of systolic blood pressure characteristics (not only the first but also the
second moment of the systolic blood pressure distribution).
As robustness check, we present matching estimates when the “true" blood pressure R
13Our main interest is in τATETm as we are more interested in the effects of treatment on the subpopulation
of treated units than on the effects on the population as a whole (Heckman et al. 1998; Imbens 2004). We will
however also present estimates of the average treatment effect (ATE), τATEm , defined as τATEm = ∑
n
i=1 Yˆi(1)−
Yˆi(0) in the Appendix.
14Selecting the number of matches involves the traditional trade-off between bias and variance, as a lower
number of matches decreases bias and increase variance whereas the other way around holds when the num-
ber of matches increases (Rosenbaum and Rubin 1985). In terms of the number of matches, it is usually
recommended to choose a small number and four matches has been shown to perform well in terms of mean-
squared error (Abadie and Imbens 2002). We therefore restrict the number of matches to be at least 4 and show
in the Appendix that our results are robust when decreasing and increasing the number of matches to 3 and
5, respectively. In cases of ties, all observations with equal R are used to compute τATEm and τATETm . Note also
that we allow the same control unit to be matched to treated unit several times, that is, we are matching obser-
vations with replacement. We also explore the robustness of our findings when shrinking the neighborhood
around each Ri to 8 and 5.
15When matching individuals not only on R but also on a set of covariates x, we impose the same dis-
tance restriction as in our benchmark analyses, where, instead of the distance being computed based on the
euclidean metric, the distance will be calculated using the mahalanobis metric.
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of respondents is based on the median of (s1, s2, s3) instead of the mean of these three mea-
surements and when R is based on the mean of the last two measures Leung et al. (2016).
In all the results using our matching estimator, we report robust standard errors estimated
using the number of matches (4 for our benchmark results, and 3 and 5 as robustness
checks) in the neighborhood of each observation.
5 Results
We first present results derived from the application of the RDD approach followed by
the corresponding results based on the matching specification. Specifically, we focus on
the following effects of receiving a referral letter: (a) changes in the average systolic and
diastolic blood pressures between 2013 and 2017, the probability of being hypertensive in
2017, the probability of having been diagnosed by a medical professional during a period
of two years prior to the follow-up interview in 2017 and on the probability of taking
blood pressure medication at the time of the interview; (b) corresponding estimates of the
effects of referral cards on health behaviors such as diet and physical exercise and on high
blood pressure-related knowledge; and (c) effects of the referral letter on overall subjective
physical and mental health of the study participants.
5.1 Effects of receiving a referral letter—RDD estimates
a) Blood pressure and hypertension diagnosis/treatment: The left graph of Figure 3 plots
the change in the mean systolic blood pressure between 2013 and 2017 with respect to the
running variable, that is the maximum of the three systolic measurements taken in 2013 (x-
axis). The bandwidths on both sides of the cutoffs are derived optimally using first order
local-polynomials (Gelman and Imbens 2019; Skovron and Titiunik 2015), and triangular
kernels to put more weight on observations closer to the cutoff.16 Each dot represents the
averages of the respective outcome in a given bin.17 The solid line represents the predicted
outcome based on those local polynomial regressions.
The causal effects of receiving a referral letter on the outcome variables are represented
in Figure 3 by the vertical distance between the two different solid lines at the cutoff (run-
ning variable Xi = 0). The top-left plot shows a drop of about 13 mmHg in the changes in
systolic blood pressure between 2017 and 2013 at the cutoff, reflecting that an individual
who received a referral letter and whose maximum systolic blood pressure was just above
the cutoff had a mean systolic blood pressure in 2017 that was on average 13 mmHg lower
than those who were right below the cutoff. A corresponding drop in blood pressure can
also be observed in the changes in diastolic blood pressure (top-middle plot), where indi-
viduals at the right of the cutoff appear to have a diastolic blood pressure to be on average
16Similar plots but using second order local polynomials can can be found in the Appendix Figure A.1.
17Bins are derived optimally using variance evenly-spaced method estimators (Calonico et al. 2014a,b, 2015,
2017).
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Figure 3: RDD estimates—Effects of receiving a referral letter on 2013–17 changes in
blood pressure, on probability of being hypertensive, diagnosed with hypertension, or
treated for hypertension in 2017
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Notes: The graphs show average blood pressure outcomes conditional on the maximum systolic blood pres-
sure in 2013. Individuals located to the right of the vertical line received the referral card in 2013. The outcome
in the top-left graph represent the average changes in systolic blood pressure from 2013 to 2017. The out-
come in the top-middle graph is the average changes in diastolic blood pressure from 2013 to 2017. In the
top-right graph, we define someone as being hypertensive if the mean of the three systolic or diastolic blood
pressure measurements was greater or equal to 140 and 90, respectively. The outcome in the bottom-left graph
is whether individuals got diagnosed by a medical professional in the two years prior to 2017. The outcome
in the bottom-right graph is whether individuals are currently taking medication during the follow-up survey
in 2017. Optimal bandwidths on both sides of the cutoffs are derived using first order local-polynomial and
triangular kernels. Bins are derived optimally using variance evenly-spaced method using spacing estimators
(Calonico et al. 2014a,b, 2015, 2017). Each dot represents the means of the respective outcome in a given bin.
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about 5 mmHg lower than their counterparts located on the left of the cutoff. The top-right
graph shows that getting a referral letter in 2013 did not only lower blood pressure, but
also reduced their probability of being hypertensive in 2017 (hypertension is indicated if
the mean of the three systolic or diastolic blood pressure measurements was greater or
equal to 140/90). A large discontinuity at the cutoff can also be observed when looking
at whether respondents were diagnosed with hypertension during the two years prior to
the follow-up interview in 2017. Indeed, the bottom-left plot in Figure 3 shows a discon-
tinuous increase of about 0.24 points in the probability of being diagnosed as a result of
receiving a referral letter for those at the cutoff. The effect of the referral card on medi-
cation is less pronounced and the discontinuity at the cutoff on whether respondents are
currently taking medication is, if any, small (bottom-right plot).
Table 2 presents the corresponding estimated coefficients of the causal effects of receiv-
ing a referral letter on our five main outcomes of interests using our RDD specification.
The estimates use first order polynomial and allow the sizes of the optimal bandwidths on
both sides of the cutoff to be different. The first row of Panel A of Table 2 shows that those
who received a referral letter in 2013 had a change in systolic blood pressure (between
2013 and 2017) that was about 12.9 mmHg lower (p-value = 0.03) than those who did not
receive a letter. This effect is statistically significant at 95%, and slightly higher (14.3, p-
value=0.016) with the inclusion of our basic set of predetermined control variables sex, age
and region (second row of each panel). Similar effects on blood pressure can be observed
on changes in mean diastolic blood pressure, where individuals who received a letter had
an average decrease in diastolic blood pressure of about 5.5 mmHg (p-value=0.053) and 5.8
mmHg (p-value=0.034) depending on whether our set of control variables are included in
the specification or not. Panel C of the same table also confirms the results shown in Figure
3: individuals who received a referral letter in 2013 were about 20 percentage points less
likely to be hypertensive in 2017 as compared to those who did not receive such letter and
whose maximum systolic blood pressure was just below the 160 cutoff. This effect is par-
ticularly precisely estimated in the specification in which the set of predetermined controls
are included in the model (p-value=0.044)
One possible explanation for the improvement in these blood pressure outcomes is that
individuals who received a referral letter indeed followed up with a health care provider
regarding their high blood pressure levels. In Panel D of Table 2 we therefore show the
effects of getting a referral letter in 2013 on the probability of being diagnosed as hyper-
tensive by a medical professional in the two years preceding the 2017 interview. For indi-
viduals located at the cutoff, receiving a referral letter caused an increase in the probability
of being diagnosed by about 24.1 percentage points (p-value = 0.023). Again, this effect is
significant and robust to the inclusion of various control variables.18
18We also investigated whether there is a discontinuity at the cutoff in diagnosis in 2013 before the blood
pressure screening. Reassuringly, we do not see a statistically significant discontinuity using several different
polynomials and controls.
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Table 2: RDD estimates—Effect of the referral letter on 2013–17 change in systolic
and diastolic blood pressure, and probability of being hypertensive, diagnosed with
hypertension, and treated for hypertension in 2017
Specification Effects Std. errors P-values OB- OB+ N- N+
A. Change in systolic blood pressure 2013–17
Linear −12.88∗∗ 5.947 0.030 23.57 18.43 312 108
Linear with controls −14.28∗∗ 5.952 0.016 21.30 18.72 275 107
B. Change in diastolic blood pressure 2013–17
Linear −5.503∗ 2.849 0.053 22.60 19.32 294 109
Linear with controls −5.790∗∗ 2.730 0.034 20.33 21.66 256 115
C. Probability of being hypertensive in 2017
Linear −0.199∗ 0.114 0.079 20.403 19.734 260 109
Linear with controls −0.225∗∗ 0.112 0.044 20.693 19.981 256 108
D. Diagnosed with hypertension in 2017
Linear 0.241∗∗ 0.106 0.023 22.22 13.29 294 87
Linear with controls 0.201∗∗ 0.101 0.046 19.25 14.50 229 90
E. Treated for hypertension in 2017
Linear 0.045 0.073 0.538 16.15 15.56 192 96
Linear with controls 0.038 0.072 0.598 14.89 15.53 160 95
Notes: The table shows estimates of the effect of receiving a referral card in 2013 on blood pressure related
outcomes using a regression discontinuity design. Change in systolic blood pressure is the difference be-
tween the average of the three systolic blood pressure measures in 2017 and in 2013. Change in diastolic
blood pressure is the difference between the average of the three diastolic blood pressure measures in 2017
and in 2013. We define someone as being hypertensive if the mean systolic or diastolic blood pressure
measurements was greater or equal to 140 and 90, respectively. Diagnosis is a dummy equal to 1 if the
respondent has been diagnosed by a medical professional in the last two years (2017 survey). Medication is
a dummy equal to 1 if the respondent is currently taking medication for blood pressure (2017 survey). All
these specifications use triangular weights and first order local polynomials. OB− and OB+ represent the
optimal bandwidths below and above the cutoffs, respectively. N− and N+ represent the number of obser-
vations included in the optimal bandwidths below and above the cutoffs, respectively. The change in sys-
tolic and diastolic blood pressure is mean(x1, x2, x3)2017−mean(x1, x2, x3)2013 with x = {systolic, diastolic}.
We use a Mean Square Error (MSE) optimal bandwidth selector. Specifications with controls includes a sex
dummy, age and region dummies. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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People who get diagnosed by a doctor or a nurse should in theory receive treatment
and advice on how to control their blood pressure with appropriate health behavior changes
such as adoption of better diet and increase in physical activity, as is commonly recom-
mended in developed countries. The causal effects of receiving a referral letter on the
probability of currently taking medication (Panel E) is about 4.5 percentage points, but
fails to be precisely estimated at conventional statistical levels. One possible explanation
for this absence of a significant effect is that the study asks whether respondents are cur-
rently taking medication but we do not know if they have been taking medication at some
point in time between 2013 and 2017.
Table A.1 in the Appendix shows that our results are not driven by the choice of the
polynomial order we use. Indeed, the effects appear very similar when using local poly-
nomials of order two. The effects on the changes in systolic blood pressure range from
-14 to -15 when using a quadratic specification, against -12.9 and -14.3 in our benchmark
specification. The effects on the probability of being hypertensive in 2017 are similar in
magnitude as well, although less precisely estimated. The effects on diagnosis and on
medication when allowing for more flexible specification are also in the ballpark of those
obtained in our linear specification. Moreover, while our benchmark specification uses tri-
angular kernels to put more weight on observations closer to the cutoff, Table A.2 in the
Appendix shows that our results are robust to using rectangular weights, which weight
all observations within the optimal bandwidths equally. Finally, we investigate whether
our results hold when we impose the optimal bandwidths on both sides of the cutoff to
be equal. Table A.4 in the Appendix shows that this is the case. In the same vein, Table
A.3 shows that our results hold when the optimal bandwidth for systolic blood pressure is
used for all the other outcomes. These robustness checks show that our results are there-
fore not driven by the choice of the sample taken into consideration in our analysis.
b) Health behaviors and knowledge: While our RDD strategy suggests some important
causal effects of receiving a referral letter on hypertension-related health outcomes, it is
of particular interest to better understand the pathways through which these effects op-
erate and especially if health behaviors other than diagnosis and medication play a role.
Specifically, we investigate whether receiving a referral letter also had an effect on diet.
Changes in health behaviors such as diet and eating habits for instance are possible chan-
nels through which the referral letter can have an effect on blood pressure. The consump-
tion of salt and sugar-sweetened beverages for instance have been shown to be strongly
associated with higher blood pressure and the incidence of hypertension (Cappuccio and
Miller 2016; He and MacGregor 2016; Malik et al. 2014).
Table 3 shows that although receiving a referral letter seems to have reduced the prob-
ability of adding extra salt to one’s plate, this effect is not precisely estimated at conven-
tional statistical levels. Opposite to what one would expect, the referral letter has had
positive effects on the probability of consuming sweet drinks in a given day and on the
total number of teaspoons of sugar individuals consume in a given day in their tea or cof-
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Table 3: RDD estimates—Effect of the referral letter on pathways for changing blood
pressure during 2013–17
Specifications Effects Std. errors P-values OB- OB+ N- N+
Pathways 1: Health Behaviors
A. Extra salt to plate
Linear −0.127 0.134 0.345 12.38 21.06 136 117
Linear with controls −0.130 0.131 0.322 12.70 23.50 133 122
B. Consume sweet drinks
Linear 0.119 0.111 0.282 20.95 14.69 260 91
Linear with controls 0.127 0.110 0.248 21.94 14.10 275 90
C. Total number of teaspoons of sugar used in tea/coffee per day
Linear 0.539 0.485 0.267 14.782 23.754 163 123
Linear with controls 0.489 0.457 0.285 14.174 21.616 160 116
D. Change in weekly MET score
Linear −60.971 39.124 0.119 12.23 16.43 134 101
Linear with controls −56.842 37.02 0.125 12.80 17.61 132 102
Pathways 2: Knowledge
A. Know about HBP
Linear −0.025 0.100 0.800 25.03 16.06 336 102
Linear with controls −0.050 0.102 0.628 24.58 15.70 320 95
B. Know symptoms
Linear 0.042 0.123 0.729 20.246 13.462 260 87
Linear with controls 0.019 0.127 0.881 18.339 13.621 214 86
C. Know about treatment
Linear −0.032 0.121 0.792 18.04 13.72 218 87
Linear with controls −0.104 0.124 0.400 16.74 12.24 188 82
Notes: The table shows estimates of the effect of receiving a referral card in 2013 on diet and knowledge
about hypertension in 2017 using a regression discontinuity design. Extra salt to plate and consumption
of sweet drinks are dummies. The knowledge measures are dummies based on whether they know what
high blood pressure is, whether they are able to name at least one of its symptoms and whether they
know that having high blood pressure required life-long treatment. All these specifications use triangular
weights and first order local polynomials. OB− and OB+ represent the optimal bandwidths below and
above the cutoffs, respectively. N− and N+ represent the number of observations included in the opti-
mal bandwidths below and above the cutoffs, respectively. We use a Mean Square Error (MSE) optimal
bandwidth selector. Specifications with controls includes a sex dummy, age and region dummies. “MET”
stands for metabolic equivalent of task and it is a measure of physical activity. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗
p < 0.01.
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fee. Individuals who received a referral letter were about 12 percentage points more likely
to consume a sweet drink in a given day and also consumed about half a spoon more of
sugar in their hot beverage per day as compared to others. These effects fail to be statis-
tically significant, which suggests that referral letters have not had any effects on change
in diet, possibly because diet recommendations are not given or are difficult to follow by
respondents diagnosed with hypertension.
Our analysis further shows a negative causal effects of receiving a referral letter on
physical activity, as evidenced in Panel D of Table 3.19 While negative, these effects again
fail to be precisely estimated.
These results suggest that, as opposed to changes in behaviors that are commonly rec-
ommended for those with hypertension in developed countries (i.e., increasing physical
activities), this is not a likely pathway through which respondents who received a referral
letter achieve a reduction in their blood pressure levels. While it is impossible to identify
the specific reasons why this is the case, one possible explanation is that the study popu-
lation is indeed physically quite active, with strenuous agricultural labor present in their
daily life and hence little space for improvement in physical activity.
Further analyses show that referral letters did not have any effect on hypertension-
related knowledge such as high blood pressure treatments and symptoms. Indeed, the
lower part of Table 3 shows that individuals at the cutoff who received a referral letter did
not have a higher probability of knowing what high blood pressure was, nor were they
more likely to know the characteristics of the symptoms of hypertension and to know that
having high blood pressure required life-long treatment. This is not surprising since our
descriptive statistics in Table 1 showed that on average this population is aware of what
hypertension is and its consequences.
c) Overall subjective health: Table 4 shows the effects of the referral letter on two indi-
cators of respondents overall subjective health: the SF12 subjective physical and mental
health score.20 Our main specification focuses on changes in the standardized SF-12 sub-
jective physical and mental health score between 2013 and 2017, and we observe an in-
crease of about half a standard deviation in both the SF-12 subjective physical and mental
19For physical activity, we use “MET” which stands for metabolic equivalent of task. MET is a measure of
oxygen consumption generated by physical activities which are ranked according to their level of intensities
relative to the standard resting metabolic rate (Ainsworth et al. 2000). We create the MET score as a weighted
physical activity score based on the number of hours per week of vigorous physical activity multiplied by
7.5 METs and the number of hours per week of moderate physical activity by 4 METs. These two subjective
coefficients have been confirmed as being reliable for objective measures of moderate and vigorous physical
activities (Brown et al. 2008). Table A.5 in the Appendix shows that getting a referral card does not change
physical activity when broken down by moderate or vigorous activity, nor does it have any effect on body
mass, as measured by BMI and waist to hip ratio.
20SF12 subjective physical health score is based on 12 questionnaire items that summarizes the overall phys-
ical health status of individuals by asking them to answer questions pertaining to their general health status,
mobility and ability to perform daily activities as well as their emotional health. Mental health score uses
the same variables but with different weights. The SF-12 has been shown to be valid and reliable and has
been widely used in different socio and demographic contexts, including in Sub Saharan African (Allotey and
Reidpath 2007; Gandek et al. 1998; Jenkinson et al. 1997; Nduka et al. 2016; Ware Jr et al. 1996).
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Table 4: RDD estimates—Effect of the referral letter on overall health status
Specifications Effects Std. errors P-values OB- OB+ N- N+
A. Change in standardized SF12 physical score 2013–17
Linear 0.529 0.323 0.101 21.29 13.49 273 85
Linear with controls 0.510 0.311 0.101 21.98 13.63 273 85
B. Change in standardized SF12 mental score 2013–17
Linear 0.511∗ 0.284 0.072 19.04 23.00 227 121
Linear with controls 0.568∗∗ 0.279 0.042 19.46 22.21 227 119
C. Change in 5-year survival expectation
Linear −0.089 0.096 0.352 21.04 26.82 260 124
Linear with controls −0.016 0.097 0.872 17.91 25.55 189 121
Note: The table shows estimates of the effect of receiving a referral card in 2013 on health in 2017 using
a regression discontinuity design. SF12 subjective physical and mental health scores are constructed
using twelve questions about general health status, mobility and ability to perform daily activities as
well as emotional health. 5-year survival expectation is the subjective probability of survival in 5 years
elicited using a methodology developed by Delavande and Kohler (2009). All these specification use
triangular weights and first order local polynomials. OB− and OB+ represent the optimal bandwidths
below and above the cutoffs, respectively. N− and N+ represent the number of observations included
in the optimal bandwidths below and above the cutoffs, respectively. We use a Mean Square Error
(MSE) optimal bandwidth selector. Specifications with controls includes a sex dummy, age and region
dummies. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
health scores. These results are very similar when we include the set of predetermined
control variables (age, sex and region). The results are statistically significant for mental
health (p-value = 0.04 when including controls) and close to be marginally significant for
the physical health score (p-value = 0.1). Although our results show no statistically sig-
nificant effects on changes in diet and negative effects on physical activity, these estimates
indicate that individuals either realize that a drop in their blood pressure is a positive im-
provement in their health or that they are taking steps to improve their health in ways we
do not fully observe. Importantly, we do not find a negative effect of giving referral letters
on mental health, as measured by the change in PHQ-9 score,21 which could have been
an ex-ante concern of this type of screening. We also do not find any effect on subjective
5-year survival expectations (last rows of Table 4).22
Finally, the first panel of Table A.6 in the Appendix shows that individuals who re-
ceived a referral letter at the cutoff did not have a higher probability of dying between
2013 and 2017.23 Having received a referral card does not seem to have any impact on
21The multi-item Patient Health Questionnaire (PHQ-9) is a widely used and validated depression instru-
ment that assess the presence and severity of depressive symptoms in clinical and general settings as well as
large population-based studies (Kroenke et al. 2001). These results are available upon request.
22Subjective survival expectations are routinely collected in the MLSFH. In particular, the MLSFH asks about
the probability of dying in 5 and in 10 years. Delavande and Kohler (2009) developed an elicitation technique
ad-hoc for a context with low literacy and numeracy.
23Among the 1,240 individuals we consider in our analysis for which we have all blood pressure measure-
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attrition either,24 as we show that receiving a referral letter in 2013 did not increase the
probability of not participating in the interview in 2017 due to refusals, hospitalizations or
temporarily absence or because of migration. Our analysis therefore does not appear to
suffer from sample selection in the follow-up survey.
5.2 Effect of receiving a referral letter—Matching/nearest-neighbor estimates
Our matching/nearest-neighbor approach for estimating the causal effect of a referral let-
ter matches treated and untreated individuals based on the mean of their three systolic
blood pressure measurements. A total of 46 individuals had mean systolic blood pressure
below 160 the cutoff for receiving a referral letter, but they received one because their max-
imum recorded blood pressure reading exceeded 160/90. These respondents constitute
the “treatment group,” and are matched with up to 161 nearest-neighbor respondents as
control group. A minimum of 4 matches is used for each individual who received a refer-
ral letter and whose mean systolic blood pressure was below 160. The average value of the
mean systolic blood pressures of the individuals in our treatment group is equal to 155.4,
with a minimum of 144 and a maximum of 159.3; in the control group, corresponding
numbers are equal to 146.8, 140 and 157, respectively.25.
a) Blood pressure and hypertension diagnosis/treatment: Table 5 shows that individuals
who received a referral letter experienced a change in systolic blood pressure of about -
12 mmHg when including our set of control variables along with the standard deviation
of the three measurements (p-value=0.02) and -6.4 mmHg in diastolic blood pressure (p-
value=0.01). These effects are rather similar in the specifications in which individuals are
matched on their mean systolic blood pressure and our set of basic predetermined control
variables only, although they are less precisely estimated. Similarly, our results indicate
negative effects on the probability of being hypertensive in 2017 and these effects are along
the lines to those reported in our RDD specification, albeit smaller and again not precisely
estimated in the specifications in which standard deviation is excluded from the matching
score. When it is included, the effect appears to be larger than our RDD estimates and
precisely estimated however. The effects on the probability of having been diagnosed
ments in 2013, we know the survival status of 1,216 of them in 2017. Out of these 1,216 individuals, 104 have
died between 2013 and 2017. This constitutes a mortality rate of about 8.6%.
24Among those who were still alive in 2017, 6 individuals refused to participate, 1 was hospitalized, 9 were
temporarily absent and 11 have migrated.
25Note that in our benchmark specification, we drop respondents whose mean systolic blood pressure is be-
low 140 to restrict our study sample of treated and untreated individuals to have a relatively common support
within the matching tolerance. As detailed in the methodology section, we restrict the distance between the
mean blood pressure between treated and untreated individuals to be less than 10 units in order to compare
individuals with similar underlying blood pressure. As discussed below, our results are robust to decreasing
and increasing the number of matches to 3 and 5, respectively. We will also show that the effects are also very
similar when reducing the distance in mean systolic blood pressure between treated and untreated individ-
uals to 8 and 5. When allowing the distance to be maximum 8, we restrict our sample to individuals with
at least 142 of mean systolic blood pressure. When the maximum distance is set to 5, our sample consists of
individuals with at least 148 of mean systolic blood pressure.
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Table 5: Matching/nearest neighbor estimates—Effect of receiving a referral letter on
change in blood pressure, diagnosis and use of medication
Change in
systolic
blood
pressure
2013–17
Change in
diastolic
blood
pressure
2013–17
Prob. of
being hy-
pertensive
(2017)
Diagnosis
(2017)
Medication
(2017)
No controls
ATET -8.484 -2.817 -.196 .277∗∗∗ .117∗∗
P-value .321 .365 .171 .000 .023
Obs. 207 207 207 207 207
Average distance 1.21 1.21 1.21 1.21 1.21
With controls
ATET -9.810∗ -2.270 -.122 .225∗∗∗ .132∗∗
P-value .078 .354 .217 .005 .010
Obs. 204 204 204 204 204
Average distance .984 .984 .984 .984 .984
With controls + SD
ATET -12.63∗∗ -6.394∗∗ -.374∗∗∗ .207∗∗ .136∗∗∗
P-value .024 .010 .000 .011 .009
Obs. 204 204 204 204 204
Average distance 1.59 1.59 1.59 1.59 1.59
Note: The table shows Average Treatment Effects on Treated (ATET) estimates of receiving a referral card in
2013 on blood pressure related outcomes using a matching estimator. Change in systolic blood pressure is the
difference between the average of the three systolic blood pressure measures in 2017 and in 2013. Change in
diastolic blood pressure is the difference between the average of the three diastolic blood pressure measures
in 2017 and in 2013. We define someone as being hypertensive if the mean systolic or diastolic blood pressure
measurements was greater or equal to 140 and 90, respectively. Diagnosis is a dummy equal to 1 if the respon-
dent has been diagnosed by a medical professional in the last two years (2017 survey). Medication is a dummy
equal to 1 if the respondent is currently taking medication for blood pressure (2017 survey). We restrict the
number of matches to be at least 4 and match respondents based on their mean systolic blood pressure in
2013, limiting the distance for possible matches to be at most 10. “Distance” represent the mean of the average
distances between each observation and their matches. “With controls” includes a sex dummy, age and region
dummies. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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with hypertension is about 27.7 percentage points when the matching is based only on
the mean of the three measurements and 21-22 percentage points when we add our set of
control variables in the matching score. It is worth noting that the ATET on both changes
in systolic/diastolic blood pressure and on the probabilities of being hypertensive and
diagnosed in 2017 are very similar to our RDD results. This would indicate that the effects
of receiving a referral letter are rather constant along the range of blood pressure between
140 and 160 mmHg.
In contrast to the RDD results, our matching analysis suggests a statistically significant
and positive effect on the probability of taking medication. The last column of Table 5
shows that individuals who received a referral letter were about 11.7 percentage points (p-
value = 0.02) more likely to be taking medication than others in our specification without
controls and 13.2 percentage points (p-value = 0.01) when we match individuals based on
our set of control variables. The effects are very similar once the standard deviation of the
three measurements are also included in the matching function (13.6 percentage points, p-
value = 0.01). These effects are about twice larger than those reported in our RDD setting.
One possible explanation could stem from the fact that the RDD specification uncovers
the treatment effect right at the 160 cutoff while the effects of our matching specification
presented in Table 5 uncovers the average treatment effect on treated for individuals with
different true levels of blood pressure. Therefore, it is not surprising that our results can
potentially be qualitatively similar but differ in magnitude and statistical power across our
two different econometric strategies.
To assess the quality of our matching, we computed the average distance in the mean
systolic blood pressure between treated individuals and their nearest neighbors that are
used in the estimation. A short average distance between these two groups would indicate
that they are similar in terms of mean systolic blood pressure and therefore comparable.
In our benchmark analysis without any controls, the average distance in systolic blood
pressure between treated and untreated individual is about 1.21 mmHg, suggesting that
our treated individuals are indeed matched with comparable individuals in terms of mean
systolic blood pressure.
Table A.7 in the Appendix shows that our results are similar when increasing or de-
creasing the number of minimum matches to 5 and 3, respectively, instead of 4. Restricting
the distance between the mean blood pressure to be at maximum 8 and 5 units instead
of 10 results results in similar average treatment effects on the treated as well (Tables A.8
and A.9 in the Appendix). Moreover, we investigate whether our results hold when as-
suming that the “true” systolic blood pressure is proxied by the median of the three blood
pressure measurements instead of the mean. Because the mean is correlated with the max-
imum value whereas the median is not, matching treated and untreated individuals based
on their median systolic blood pressure could better reflect the actual effect of getting a re-
ferral letter by comparing individuals that are more similar in terms of their “true blood”
pressure. Table A.10 in the Appendix shows that are results are once again very similar.
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Conclusion is identical when we consider the last two systolic blood pressure measure-
ments instead of the three we have at hand. As the first blood pressure measurement
could be more prone to measurement error and less reflect the “true” underlying blood
pressure of individuals, due to stress, anxiety and so on, taking into account only the last
two measurements could potentially better represent individual’s “true” blood pressure.
We show in Table A.11 of the Appendix that our results are very robust to that restriction
as well. 26
b) Health behaviors and knowledge: As it was the case in our RDD analysis, we investi-
gate the pathways through which the referral letters could have had an effect on change
in blood pressure. Tables 6 present the corresponding matching estimates of the ATET of
getting a referral letter on the various pathways discussed above. Again, our matching
analysis suggests no statistically significant changes in high blood pressure-related knowl-
edge. Our results do suggest however a change in health behaviors. More specifically,
while receiving a referral card did not have any effect on the probability of adding extra
salt to one’s plate and on consuming sweet drinks in a given day, our results indicate that
individuals who received a referral letter consume more teaspons of sugar in their tea or
coffee per day than others (about 1 teaspoon depending on the specification). They were
also more likely to decrease their physical activity between 2013 and 2017, as evidenced
in the last column of Table 6.27 These results are in line with those obtained in our RDD
specification, although they are precisely estimated in our matching analysis whereas they
were not in our RDD strategy.
These results are surprising because they go against the usual “Western” recommen-
dations to treat high blood pressure. While usual recommendations in developed coun-
tries advocate a decrease in salt and sugar consumption, in conjunction with increase in
physical activity, individuals who received a referral letter do not seem to follow these
guidelines in this context. While it is not possible to find a precise reason for this behav-
ior, possible explanations are: 1) presence of a substitution effect of medication, where
individuals rely on medical treatment rather than behavior changes to control their blood
pressure; 2) given the very poor context characterized by dietary restrictions, individuals
cannot “afford” to change their diets; 3) given the high intensity agricultural labor context,
individuals are physically active on a daily basis and there is little “room” to make further
improvements.
26Table A.12 in the Appendix presents the ATE instead the ATET. The quality of the matches is not as good
in the ATE as in the ATET because ATE requires all individuals who have not received a referral letter to be
matched with individuals who did received a referral letter. As shown in 3, those who received a referral letter
are not uniformly distributed in the range of the mean systolic blood pressure considered in our matching
strategy. This means that a large share of the individuals who did not receive a referral letter is matched with
individuals who have on on average higher mean systolic blood pressure. The effects presented in Table A.12
are however in line with those presented in our benchmark specification.
27Table A.13 shows that the decrease in physical activity is in fact due to a drop in vigorous physical activity.
It is also worth nothing that the drop in physical activity does not seem to be accompanied by an increase in
body mass, either measured in terms of BMI or waist-to-hip ratio.
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Table 6: Matching/nearest neighbor estimates—–Effect of receiving a referral letter on hypertension knowledge and
diet
Knowledge Health Behaviors
Know
about
HBP
Know
symptoms
Know
about
treatment
Extra
salt to
plate
Consume
sweet
drinks
# teaspoons
sugar used in
tea/coffee
per day
Change in
weekly
MET score
No controls
ATET .115 .072 .056 -.018 .099 .765 -44.1
P-value .473 .663 .714 .885 .514 .120 .100
Obs. 207 207 207 207 207 207 204
Distance 1.21 1.21 1.21 1.21 1.21 1.21 1.23
With controls
ATET -.077 -.115 .009 -.213∗ .067 1.30∗∗∗ -77.9∗∗
P-value .260 .273 .920 .051 .423 .001 .005
Obs. 204 204 204 204 204 204 202
Average distance .984 .984 .984 .984 .984 .984 .995
With controls+SD
ATET -.071 -.126 .097 -.094 -.029 .923∗∗ -137∗∗∗
P-value .303 .193 .291 .358 .733 .010 .000
Obs. 204 204 204 204 204 204 202
Average distance 1.59 1.59 1.59 1.59 1.59 1.59 1.59
Notes: The table shows Average Treatment Effects on Treated (ATET) estimates of receiving a referral card in 2013 on knowledge about hypertension
and diet in 2017 using a matching estimator. The knowledge measures are dummies based on whether they know what high blood pressure is,
whether they are able to name at least one of its symptoms and whether they know that having high blood pressure required life-long treatment.
Extra salt to plate and consumption of sweet drinks are dummies. We restrict the number of matches to be at least 4 and match respondents based
on their mean systolic blood pressure in 2013, limiting the distance for possible matches to be at most 10. “Distance” represent the mean of the
average distances between each observation and their matches. “With controls” includes a sex dummy, age and region dummies. “MET” stands
for metabolic equivalent of task and it is a maeasure of physical activity. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 7: Matching/nearest neighbor estimates—–Effect of receiving a referral letter on
overall subjective health
Change in
standardized SF12
physical score
Change in
standardized SF12
mental score
Change in 5-year
survival expectation
2013–17 2013–17 2013–17
No controls
ATET .729∗∗ .588∗ -.326∗∗
P-value .046 .072 .026
Obs. 201 201 190
Distance 1.239 1.239 1.308
With controls
ATET .070 .200 -.039
P-value .757 .476 .656
Obs. 201 201 190
Average distance 1.000 1.000 1.031
With controls + SD
ATET -.013 .111 .033
P-value .954 .690 .688
Obs. 201 201 190
Average distance 1.603 1.603 1.641
Note: The table shows Average Treatment Effects on Treated (ATET) estimates of receiving a referral card
in 2013 on health in 2017 using a matching estimator. SF12 subjective physical and mental health scores are
constructed using twelve questions about general health status, mobility and ability to perform daily activities
as well as emotional health. 5-year survival expectation is the subjective probability of survival in 5 years
elicited using a methodology developed by Delavande and Kohler (2009). We restrict the number of matches to
be at least 4 and match respondents based on their mean systolic blood pressure in 2013, limiting the distance
for possible matches to be at most 10. “Distance” represent the mean of the average distances between each
observation and their matches. “With controls” includes a sex dummy, age and region dummies. ∗ p < 0.1, ∗∗
p < 0.05, ∗∗∗ p < 0.01.
c) Overall subjective health: Table 7 shows the effects of receiving a referral letter on sub-
jective physical and mental health SF12 scores and 5-year survival expectation. Results on
these three outcome variables are not consistent across the different specifications and it is
therefore hard to draw any hard evidence on the effects of the referral card on subjective
health based on the matching specification. Finally, the second panel of Table A.6 shows
that receiving a referral letter did not have any statistically significant effect on the proba-
bility of dying between 2013 and 2017, nor has it had any impact on attrition. This confirms
the RDD results presented before that our analysis is not biased due to sample selection.
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Table 8: Summary of the causal effects found in this study
Blood
pressure
Hyper-
tension
Diagnosis Medi-
cation
Know-
ledge
Risky
health
behav-
iors
Subjective
health
RDD ⇓ ⇓ ⇑ − − − ↑
Matching ⇓ ⇓ ⇑ ⇑ − ↑ −
Note: Upwards (downwards) double arrows show the presence of positive (negative) and statistically sig-
nificant effects at conventional levels (p-value=0.05). Upwards (downwards) arrows show the presence of
positive (negative) and statistically significant effects at conventional levels on some dimensions of the char-
acteristics considered. Dashes represent lack of statistically significant effects or not consistent/ambiguous
effects across specifications.
6 Conclusions
This study is the first to provide estimates of the long-term causal effects on health outcomes
of a population-based NCD-focused health screening in a SSA low-income population.
Filling this knowledge gap is critical because of NCD screening interventions have been
heralded as a critical component of possible responses to the emerging NCDs epidemic
in LMICs (Geldsetzer et al. 2019; Islam et al. 2014; WHO 2013a). Specifically, we analyze
the effects of a referral letter given to at-risk individuals in Malawi who were measured
with high blood pressure and therefore face a heightened likelihood of CVDs. Comparing
individuals whose blood pressure was just above the cutoff that determines whether a
referral letter is given to those just below that cutoff, we are able to identify the causal
effects of at-risk individuals receiving a referral letter. Outcomes of interest are measured
four years after the screening, and include hypertension as well as health behavior and
subjective health indicators.
A summary of the main results is presented in Table 8. Our analysis shows that screen-
ing was effective in reducing both systolic and diastolic blood pressure among at-risk indi-
viduals. Our findings indicate that individuals who received a referral letter in 2013 were
also less likely to be hypertensive in the follow-up survey four years later in 2017. We
also show that at-risk individuals were more likely to be diagnosed as hypertensive by a
medical professional as a result of getting the referral letter, and we find evidence that they
were also more likely to be taking medication for blood pressure at the time of the inter-
view. Our key findings are robust to various sample selections and econometric methods,
which reinforces both the internal and external validity of our findings, the latter being
particularly relevant to policy makers.
Our study also shows that individuals do not seem to modify other health behaviors
that could reduce blood pressure such as lowering their consumption of salt and sugar.
Although this might initially be surprising, it is consistent with several aspects of the local
LIC context. For example, individuals, including persons at elevated risk of CVDs, may
Penn Population Center Working Paper 2020-41
https://repository.upenn.edu/psc_publications/41
30
Health Screening for Emerging Disease Burdens
have very limited options in adjusting their health behaviors along these margins. Hyper-
tension is also driven by distinctive risk factors (e.g., obesity and Western diets continue
to be rare; see Kohler et al. 2018b), therefore rendering conventional behavioral responses
less effective. In addition, behavioral guidelines for the treatment of hypertension are de-
veloped mostly on research from high- and middle-income countries, and are often not
adopted to the realities of LIC contexts.
If anything, we observe a behavioral response that is the opposite to what one would
expect given the current “Western” recommendations in terms of high blood pressure
management. Our findings suggest that at-risk individuals who receive a referral letter
tend to consume more sugar and are less physically active. While the precise reasons for
these behavioral changes related to diet and physical activity are difficult to determine,
several possible explanations exist. For instance, this could be due to a substitution ef-
fect, with individuals relying on medical treatment rather than behavior changes to con-
trol their blood pressure. Alternatively, given an overall unbalanced and calorie-restricted
diet, individuals may also be very limited in their options to make any changes in their
food consumption, and recommendations to reduce specific food consumption may even
be perceived counterfactual. Due to the high intensity of agricultural labor, being physi-
cally active is also part of individuals’ daily routine with only limited abilities for further
improvement. Interestingly, and consistent with our finding that at-risk individuals are
less active after receiving a referral latter, 80% of respondents reported that their blood
pressure is informative about their ability to work (which is generally not the case).
The long-term effects of receiving a referral letter pertain not only to hypertension per
se, but have spillover effects on other health dimensions. Specifically, we find some evi-
dence that at-risk individuals who received a referral letter perceived their mental health
more favorably than others. The effects are statistically significant only in the RDD specifi-
cation, but we can at least rule out any negative effects of learning about having high blood
pressure on subjective health. We were also not able to clearly identify which factors above
and beyond the increase in the use of hypertension medications can explain this pattern.
Overall, our findings are important in that they document the effectiveness of a simple
and inexpensive population-based health screening that resulted in sustained increases in
health-seeking behaviors for NCDs among at-risk individuals in a rural LIC context. Sim-
ilar to related findings about preventive versus curative health care seeking among the
poor (Banerjee and Duflo 2011), our study thus shows that individuals seem to be willing
to spend time and effort to treat NCDs (in our case, through hypertension medication),
but they are less willing to modify their habits and day-to-day routines as risk-reduction
strategies to prevent or delay the onset of such NCDs. Given the lack of conventional risk
factors for hypertension in SSA LICs, the behavioral responses to high blood pressure are
not fully clear from a public health/biomedical perspective. On the one hand, recommen-
dations from the Western context, like losing weight or increasing physical activity, are
not necessarily the appropriate recommendations in LICs. Other recommendations like
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reduction in salt consumption may be hard to follow, as salt use is probably deeply in-
grained in the local food culture and may also play important roles in the preservation
of food. On the other hand, the possibilities of at-risk individuals to respond to the re-
ferral card with health care seeking are often limited because access to care is difficult
and costly, and service providers are often ill-prepared to manage or treat NCDs. Yet, as
our findings illustrate, diagnosis and treatment through medication seems to be the pri-
mary pathway through which at-risk individuals managed to reduce their hypertension
risk subsequent to receiving a referral letter. Our results suggest that individuals do not
find information about their high blood pressure level distressing in the sense that we do
not observe any negative effects on self-rated mental health and depressive symptoms in
at-risk individuals who were given a referral letter. This is an important finding because
a potential downside of population-based screenings are concerns about possible negative
mental health implications of alerting individuals about underlying disease risk factors
when they may have limited options to prevent or treat the respective diseases.
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A Online Appendix: Additional results
Figure A.1: Effects of getting a referral letter on changes in systolic blood pressure (top
left), changes in diastolic blood pressure (top middle), the probability of being hyper-
tensive in 2017 (top right), hypertension diagnosis (bottom left) and hypertension med-
ication (bottom right) at the cutoff.
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Note: The graphs show average blood pressure outcomes conditional on the maximum systolic blood pressure
in 2013. Individuals right of the vertical line received the referral card in 2013. The outcome in the top-left
graph is the average change in systolic blood pressure from 2013 to 2017. The outcome in the top-middle graph
is the average change in diastolic blood pressure from 2013 to 2017. In the top-right graph, we define someone
as being hypertensive if the mean systolic or diastolic blood pressure measurements was greater or equal to
140 and 90, respectively. The outcome in the bottom-left graph is whether individuals got diagnosed by a
medical professional in the last two years (2017 survey). The outcome in the bottom-right graph is whether
individuals are currently taking medication (2017 survey). Optimal bandwidths on both sides of the cutoffs are
derived using 2nd order local-polynomial and triangular kernels. Bins are derived optimally using variance
evenly-spaced method using spacing estimators (Calonico et al. 2014a,b, 2015, 2017). Each dot represents the
means of the respective outcome in a given bin.
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Table A.1: Results of the RDD specification using 2nd order local polynomials
Specifications Effects Std. errors P-values OB- OB+ N- N+
A. Change in systolic blood pressure
Quadratic −14.05∗∗ 6.918 0.042 31.40 32.79 427 153
Quadratic with controls −15.06∗∗ 7.015 0.032 26.95 34.31 343 154
B. Change in diastolic blood pressure
Quadratic −5.951∗ 3.447 0.084 27.82 31.82 364 150
Quadratic with controls −4.701 3.539 0.184 21.55 31.44 275 148
C. Probability of being hypertensive in 2017
Quadratic −0.195 0.143 0.173 28.02 25.88 373 127
Quadratic with controls −0.217 0.139 0.118 30.87 25.05 405 126
D. Diagnosis
Quadratic 0.257∗∗ 0.129 0.047 22.27 21.88 294 117
Quadratic with controls 0.221∗ 0.123 0.073 20.95 24.00 256 125
E. Medication
Quadratic 0.045 0.090 0.618 18.83 27.51 218 136
Quadratic with controls 0.038 0.086 0.655 18.60 29.10 214 142
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. All these specifications use triangular weights. OB− and OB+
represent the optimal bandwidths below and above the cutoffs, respectively. N− and N+ represent the
number of observations included in the optimal bandwidths below and above the cutoffs, respectively.
The change in systolic and diastolic blood pressure is mean(x1, x2, x3)2017 − mean(x1, x2, x3)2013 with
x = {systolic, diastolic}. We use a Mean Square Error (MSE) optimal bandwidth selector.
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Table A.2: Results of the RDD specification using rectangular weights
Specification Effects Std. errors P-values OB- OB+ N- N+
A. Change in systolic blood pressure
Linear −14.79∗∗ 5.878 0.012 21.07 13.37 280 87
Linear with controls −15.09∗∗ 6.026 0.012 18.04 14.38 214 90
B. Change in diastolic blood pressure
Linear −7.055∗∗ 3.119 0.024 16.57 12.03 192 83
Linear with controls −7.892∗∗ 3.083 0.011 13.80 13.23 148 86
C. Probability of being hypertensive in 2017
Linear −0.190∗ 0.110 0.085 18.82 16.79 218 102
Linear with controls −0.221∗∗ 0.109 0.042 18.95 17.29 214 103
D. Diagnosis
Linear 0.256∗∗ 0.112 0.022 13.61 10.79 151 69
Linear with controls 0.185∗ 0.108 0.088 11.58 11.89 118 76
E. Medication
Linear 0.061 0.076 0.425 18.22 10.71 218 69
Linear with controls 0.012 0.072 0.870 18.18 11.07 214 76
Note: The table shows estimates of the effect of receiving a referral card in 2013 on blood pressure
related outcomes using a regression disconinuity design. Change in systolic blood pressure is the
difference between the average of the three systolic blood pressure measures in 2017 and in 2013.
Change in diastolic blood pressure is the difference between the average of the three diastolic blood
pressure measures in 2017 and in 2013. We define someone as being hypertensive if the mean systolic
or diastolic blood pressure measurements was greater or equal to 140 and 90, respectively. Diagnosis
is a dummy equal to 1 if the respondent has been diagnosed by a medical professional in the last
two years (2017 survey). Medication is a dummy equal to 1 if the respondent is currently taking
medication for blood pressure (2017 survey). These specifications use rectangular weights instead
of triangular ones. OB− and OB+ represent the optimal bandwidths below and above the cutoffs,
respectively. N− and N+ represent the number of observations included in the optimal bandwidths
below and above the cutoffs, respectively. The change in systolic and diastolic blood pressure is
mean(x1, x2, x3)2017 − mean(x1, x2, x3)2013 with x = {systolic, diastolic}. We use a Mean Square Error
(MSE) optimal bandwidth selector. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
Penn Population Center Working Paper 2020-41
https://repository.upenn.edu/psc_publications/41
41
Health Screening for Emerging Disease Burdens
Table A.3: Results of the RDD specification using identical optimal bandwidths for
all four main outcomes
Specifications Effects Std. errors P-values OB- OB+ N- N+
A. Change in systolic blood pressure
Linear −12.88∗∗ 5.947 0.030 23.57 18.43 312 108
Linear with controls −14.28∗∗ 5.952 0.016 21.30 18.72 275 107
B. Change in diastolic blood pressure
Linear −5.439∗ 2.867 0.058 23.57 18.43 312 108
Linear with controls −6.029∗∗ 2.811 0.032 21.30 18.72 275 107
C. Probability of being hypertensive in 2017
Linear −0.197∗ 0.111 0.076 23.57 18.43 312 108
Linear with controls −0.228∗∗ 0.112 0.042 21.30 18.76 275 107
D. Diagnosis
Linear 0.225∗∗ 0.094 0.017 23.57 18.43 312 109
Linear with controls 0.192∗∗ 0.091 0.035 21.30 18.72 275 108
E. Medication
Linear 0.063 0.066 0.339 23.57 18.43 312 109
Linear with controls 0.042 0.064 0.515 21.30 18.72 275 108
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. These specifications use same optimal bandwidths for
the four main outcome variables. OB− and OB+ represent the optimal bandwidths below and above
the cutoffs, respectively. N− and N+ represent the number of observations included in the optimal
bandwidths below and above the cutoffs, respectively. The change in systolic and diastolic blood
pressure is mean(x1, x2, x3)2017 − mean(x1, x2, x3)2013 with x = {systolic, diastolic}. We use a Mean
Square Error (MSE) optimal bandwidth selector.
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Table A.4: Results of the RDD specification restricting the bandwidth to be the
same bandwidths on both sides of the cutoffs
Specifications Effects Std. errors P-values OB- OB+ N- N+
A. Change in systolic blood pressure
Linear −13.04∗∗ 6.162 0.034 18.85 18.85 218 108
Linear with controls −14.24∗∗ 6.039 0.018 19.04 19.04 229 108
B. Change in diastolic blood pressure
Linear −5.697∗ 2.937 0.052 19.31 19.31 233 109
Linear with controls −5.777∗∗ 2.717 0.034 21.35 21.35 275 115
C. Probability of being hypertensive in 2017
Linear −0.192∗ 0.106 0.070 23.22 23.22 312 122
Linear with controls −0.219∗∗ 0.105 0.037 23.18 23.18 307 121
D. Diagnosis
Linear 0.236∗∗ 0.112 0.036 13.44 13.44 151 87
Linear with controls 0.201∗ 0.105 0.056 14.32 14.32 160 90
E. Medication
Linear 0.047 0.077 0.543 14.30 14.30 163 91
Linear with controls 0.036 0.075 0.629 14.05 14.05 160 90
Note: The table shows estimates of the effect of receiving a referral card in 2013 on blood pressure
related outcomes using a regression disconinuity design. Change in systolic blood pressure is the
difference between the average of the three systolic blood pressure measures in 2017 and in 2013.
Change in diastolic blood pressure is the difference between the average of the three diastolic blood
pressure measures in 2017 and in 2013. We define someone as being hypertensive if the mean systolic
or diastolic blood pressure measurements was greater or equal to 140 and 90, respectively. Diagnosis
is a dummy equal to 1 if the respondent has been diagnosed by a medical professional in the last
two years (2017 survey). Medication is a dummy equal to 1 if the respondent is currently taking
medication for blood pressure (2017 survey). All these specifications use triangular weights. OB−
and OB+ represent the bandwidths below and above the cutoffs, respectively, and are restricted to
be identical. N− and N+ represent the number of observations included in the optimal bandwidths
below and above the cutoffs, respectively. The change in systolic and diastolic blood pressure is
mean(x1, x2, x3)2017 − mean(x1, x2, x3)2013 with x = {systolic, diastolic}. We use a Mean Square Error
(MSE) optimal bandwidth selector. ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A.5: Results of the RDD specification on the change in physical activity and
weight
Specification Effects Std. errors P-values OB- OB+ N- N+
A. Change weekly hours of moderate activity
Linear −1.803 4.265 0.672 24.52 23.39 323 123
Linear with controls −1.947 4.331 0.653 23.33 22.74 306 120
B. Change weekly hours of vigorous activity
Linear −7.931 4.900 0.106 11.16 14.52 119 90
Linear with controls −8.973∗ 4.907 0.067 10.91 14.75 102 89
C. Change in weight
Linear 0.143 1.529 0.925 19.95 13.36 223 85
Linear with controls −0.048 1.530 0.975 19.79 13.94 223 85
D. Change in BMI
Linear −0.401 0.588 0.495 18.52 14.22 209 88
Linear with controls −0.519 0.619 0.402 17.69 13.66 197 84
E. Waist to hip ratio (2017)
Linear −0.017 0.016 0.298 19.17 19.39 226 108
Linear with controls −0.025 0.016 0.123 19.87 19.56 224 107
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. All these specification use triangular weights. OB− and OB+
represent the optimal bandwidths below and above the cutoffs, respectively. N− and N+ represent the
number of observations included in the optimal bandwidths below and above the cutoffs, respectively.
The change in systolic and diastolic blood pressure is mean(x1, x2, x3)2017 − mean(x1, x2, x3)2013 with
x = {systolic, diastolic}. We use a Mean Square Error (MSE) optimal bandwidth selector.
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Table A.6: Causal effects on mortality and attrition
1. Regression Discontinuity Design
Effects Std. errors P-values OB- OB+ N- N+
A. Mortality
Linear 0.019 0.082 0.814 18.37 14.92 252 106
Linear with controls 0.057 0.078 0.466 21.09 14.59 318 106
B. Attrition
Linear 0.000 0.045 0.996 31.67 17.30 445 106
Linear with controls 0.010 0.044 0.817 29.77 16.71 414 104
2. Matching Strategy
ATET P-value Obs. Average distance
A. Mortality
No controls .013 .936 242 .871
With controls -.033 .593 242 .916
With controls + SD -.009 .883 242 1.538
B. Attrition
No controls .010 .666 218 .920
With controls .015 .710 218 .959
With controls + SD -.039 .334 218 1.575
Note: The table shows the effect of the referral card given in 2013 on mortality and attrition in 2017. Specifica-
tions in the RDD use triangular weights. OB− and OB+ represent the optimal bandwidths below and above
the cutoffs, respectively. N− and N+ represent the number of observations included in the optimal bandwidths
below and above the cutoffs, respectively. We use a Mean Square Error (MSE) optimal bandwidth selector. ∗
p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A.7: Results of the matching estimations on the main outcomes variables with
different restrictions on the number of minimum matches
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
A. At least 3 matches
No controls
ATET -3.867 -1.316 -.113 .272∗∗∗ .112∗∗
P-value .685 .690 .313 .000 .032
Obs. 207 207 207 207 207
Distance .933 .933 .933 .933 .933
With controls
ATET -9.471∗ -1.628 -.078 .292∗∗∗ .135∗∗∗
P-value .089 .500 .439 .000 .009
Obs. 204 204 204 204 204
Average distance .904 .904 .904 .904 .904
With controls + SD
ATET -6.418 -2.750 -.290∗∗∗ .257∗∗∗ .162∗∗∗
P-value .271 .272 .002 .002 .003
Obs. 204 204 204 204 204
Average distance 1.503 1.503 1.503 1.503 1.503
B. At least 5 matches
No controls
ATET -8.164 -2.622 -.204 .289∗∗∗ .123∗∗
P-value .293 .375 .178 .000 .0150
Obs. 207 207 207 207 207
Distance 1.228 1.228 1.228 1.228 1.228
With controls
ATET -10.39∗ -2.416 -.126 .223∗∗∗ .128∗∗
P-value .051 .304 .197 .005 .018
Obs. 204 204 204 204 204
Average distance 1.057 1.057 1.057 1.057 1.057
With controls + SD
ATET -12.18∗∗ -4.995∗∗ -.226∗∗ .235∗∗∗ .171∗∗∗
P-value .028 .040 .021 .004 .002
Obs. 204 204 204 204 204
Average distance 1.665 1.665 1.665 1.665 1.665
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 3 (Panel A) and 5 (Panel B) and match respondents based on their mean systolic blood
pressure in 2013, limiting the distance for possible matches to be at most 10. "Distance" represent the mean of
the average distances between each observation and their matches. "With controls" includes a sex dummy,
age and region dummies.Penn Population Center Working Paper 2020-41
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Table A.8: Results of the matching estimations on the main outcomes variables, restrict-
ing possible matches to be within a distance of 8 maximum
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
No controls
ATET -8.484 -2.817 -.196 .277∗∗∗ .117∗∗
P-value .321 .365 .171 .000 .023
Obs. 181 181 181 181 181
Distance 1.21 1.21 1.21 1.21 1.21
With controls
ATET -9.046 -1.769 -.100 .215∗∗∗ .118∗∗
P-value .101 .463 .309 .008 .026
Obs. 178 178 178 178 178
Average distance 1.055 1.055 1.055 1.055 1.055
With controls + SD
ATET -7.386 -2.029 -.266∗∗∗ .199∗∗ .093∗
P-value .206 .404 .006 .015 .077
Obs. 178 178 178 178 178
Average distance 1.659 1.659 1.659 1.659 1.659
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 4 and match respondents based on their mean systolic blood pressure in 2013, limiting
the distance for possible matches to be at most 8. "Distance" represent the mean of the average distances
between each observation and their matches. "With controls" includes a sex dummy, age and region dummies.
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Table A.9: Results of the matching estimations on the main outcomes variables, restrict-
ing possible matches to be within a distance of 5 maximum
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
No controls
ATET -9.440 -2.960 -.216 .253∗∗∗ .079∗
P-value .299 .367 .156 .001 .089
Obs. 106 106 106 106 106
Distance 1.275 1.275 1.275 1.275 1.275
With controls
ATET -6.068 -.024 -.049 .260∗∗∗ .115∗∗
P-value .301 .992 .648 .003 .0250
Obs. 105 105 105 105 105
Average distance 1.38 1.38 1.38 1.38 1.38
With controls + SD
ATET -10.66∗ -2.107 -.313∗∗∗ .234∗∗∗ .120∗∗
P-value .057 .401 .001 .0090 .023
Obs. 105 105 105 105 105
Average distance 1.978 1.978 1.978 1.978 1.978
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 4 and match respondents based on their mean systolic blood pressure in 2013, limiting
the distance for possible matches to be at most 5. "Distance" represent the mean of the average distances
between each observation and their matches. "With controls" includes a sex dummy, age and region dummies.
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Table A.10: Results of the matching estimations on the main outcomes variables, match-
ing observations based on their median systolic blood pressure value instead of mean
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
No controls
ATET -6.109 -3.058 -.121 .289∗∗∗ .119∗∗
P-value .325 .223 .161 .000 .027
Obs. 256 256 256 257 257
Distance .726 .726 .726 .773 .773
With controls
ATET -9.530∗ -3.590 -.087 .209∗∗ .095∗
P-value .087 .119 .343 .011 .096
Obs. 253 253 253 254 254
Average distance .797 .797 .796 .796 .796
With controls + SD
ATET -8.729 -6.783∗∗∗ -.163∗ .195∗∗ .102∗
P-value .125 .003 .078 .016 .077
Obs. 253 253 253 254 254
Average distance 1.34 1.34 1.34 1.34 1.34
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 4 and match respondents based on their median systolic blood pressure in 2013, limiting
the distance for possible matches to be at most 10. "Distance" represent the mean of the average distances
between each observation and their matches. "With controls" includes a sex dummy, age and region dummies.
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Table A.11: Results of the matching estimations on the main outcome variables, using
the last two measurements only
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
No controls
ATET -8.681 -2.590 -.180 .278∗∗∗ .107∗∗
P-value .131 .273 .101 .000 .027
Obs. 232 232 232 232 232
Distance .800 .800 .800 .800 .800
With controls
ATET -9.586∗ -1.471 -.171∗ .244∗∗∗ .086∗
P-value .083 .540 .076 .001 .093
Obs. 228 228 228 228 228
Average distance .909 .909 .909 .909 .909
With controls + SD
ATET -11.13∗∗ -2.460 -.148 .224∗∗∗ .084
P-value .033 .268 .128 .006 .135
Obs. 228 228 228 228 228
Average distance 1.338 1.338 1.338 1.338 1.338
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 4 and match respondents based on their median systolic blood pressure in 2013, limiting
the distance for possible matches to be at most 10. "Distance" represent the mean of the average distances
between each observation and their matches. "With controls" includes a sex dummy, age and region dummies.
Here, we are taking into account only the last two measurements to compute the mean systolic blood pressure.
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Table A.12: Results of the matching estimations representing the Average Treatment
Effects (ATE)
Change in
systolic
blood
pressure
Change in
diastolic
blood
pressure
Prob. of
being hy-
pertensive
(2017)
Diagnosis Medication
No controls
ATE -2.798 -1.901 -.024 .454∗∗∗ .249∗
P-value .751 .671 .883 .003 .071
Obs. 207 207 207 207 207
Distance 1.21 1.21 1.21 1.21 1.21
With controls
ATE -3.637 -2.652 -.001 .351∗∗∗ .205∗∗∗
P-value .484 .278 .989 .000 .002
Obs. 204 204 204 204 204
Average distance .984 .984 .984 .984 .984
With controls + SD
ATE -18.94∗∗∗ -5.890∗∗∗ .014 .372∗∗∗ -.005
P-value .000 .007 .885 .000 .9354
Obs. 204 204 204 204 204
Average distance 1.59 1.59 1.59 1.59 1.59
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects (ATE) of getting
a referral card on the various outcomes listed in the columns. We restrict the number of matches to be at least 4
and match respondents based on their mean systolic blood pressure in 2013, limiting the distance for possible
matches to be at most 10. "Distance" represent the mean of the average distances between each observation
and their matches. "With controls" includes a sex dummy, age and region dummies.
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Table A.13: Results of the matching estimations on the change in physical activity and
weight
Change
weekly
hours of
moderate
activity
Change
weekly
hours of
vigorous
activity
Change in
weight
Change in
BMI
Waist to
hip ratio
(2017)
No controls
ATET 3.790 -7.585∗∗ -2.305 -1.073 -.033
P-value .370 .023 .464 .264 .160
Obs. 206 204 200 200 202
Distance 1.21 1.234 1.211 1.211 1.204
With controls
ATET 4.354 -12.42∗∗∗ -.061 -.048 -.034
P-value .261 .001 .953 .926 .108
Obs. 204 202 200 200 201
Average distance .984 .995 1.003 1.003 .998
With controls + SD
ATET -22.54∗∗∗ -5.302 -1.446 -.134 .015
P-value .000 .109 .139 .765 .348
Obs. 204 202 200 200 201
Average distance 1.59 1.594 1.613 1.613 1.612
Note: ∗ p < 0.1, ∗∗ p < 0.05, ∗∗∗ p < 0.01. The results represent the Average Treatment Effects on Treated
(ATET) of getting a referral card on the various outcomes listed in the columns. We restrict the number of
matches to be at least 4 and match respondents based on their median systolic blood pressure in 2013, limiting
the distance for possible matches to be at most 10. "Distance" represent the mean of the average distances
between each observation and their matches. "With controls" includes a sex dummy, age and region dummies.
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